Skip to main content
Erschienen in: World Journal of Urology 2/2011

01.04.2011 | Original Article

Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways

verfasst von: J. N. Cornu, B. Merlet, O. Cussenot, G. Cancel-Tassin, C. Ciofu, G. Amarenco, F. Haab

Erschienen in: World Journal of Urology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Although existence of genetic factors predisposing to urinary incontinence in women is widely admitted, precise molecular and genetic variations implicated are still unknown. Given the established influence of steroids metabolism in incontinence, we studied the correlation between polymorphisms of genes of oestrogen/androgen pathways and urinary incontinence in women, in order to raise evidence of genetic susceptibility.

Methods

A case–control study included 121 cases and 66 controls. Age, familial history of incontinence, gynaecologic history and age of menopause were collected. Patients were classified into three groups: control, urge urinary incontinence (UUI), stress urinary incontinence (SUI). Genetic polymorphisms were determined after amplification by PCR for the following genes: CYP-19, CYP17, androgen receptor (AR) and oestrogen receptor (ESR-1). Statistical analysis was performed to study correlation between genotype and presence of a subtype of incontinence.

Results

A total of 187 patients were analysed: 66 were controls, 30 presented UUI and 107 presented SUI. Patients presenting incontinence had significantly more often familial history of incontinence than controls. AR polymorphism (combination of 2 alleles containing more than 21 CAG repeats) is significantly associated with UUI (P = 0.02). Polymorphisms of ESR-1, CYP17 and CYP19 were not associated with any subtype of urinary incontinence.

Conclusions

This study shows that AR polymorphism is linked to genetic susceptibility to urinary incontinence. This result suggests that this disease is partly gene-related and encourages larger studies to explore the genetics factors of urinary incontinence.
Literatur
2.
Zurück zum Zitat Altman D, Forsman M, Falconer C, Lichtenstein P (2008) Genetic influence on stress urinary incontinence and pelvic organ prolapse. Eur Urol 54:918–922PubMedCrossRef Altman D, Forsman M, Falconer C, Lichtenstein P (2008) Genetic influence on stress urinary incontinence and pelvic organ prolapse. Eur Urol 54:918–922PubMedCrossRef
3.
Zurück zum Zitat Fenner DE, Trowbridge ER, Patel DA, Fultz NH, Miller JM, Howard D, DeLancey JO (2008) Establishing the prevalence of incontinence study: racial differences in women’s patterns of urinary incontinence. J Urol 179:1455–1460PubMedCrossRef Fenner DE, Trowbridge ER, Patel DA, Fultz NH, Miller JM, Howard D, DeLancey JO (2008) Establishing the prevalence of incontinence study: racial differences in women’s patterns of urinary incontinence. J Urol 179:1455–1460PubMedCrossRef
4.
Zurück zum Zitat Jackson RA, Vittinghoff E, Kanaya AM, Miles TP, Resnick HE, Kritchevsky SB, Simonsick EM, Brown JS (2004) Urinary incontinence in elderly women: findings from the health, aging, and body composition study. Obstet Gynecol 104:301–307PubMedCrossRef Jackson RA, Vittinghoff E, Kanaya AM, Miles TP, Resnick HE, Kritchevsky SB, Simonsick EM, Brown JS (2004) Urinary incontinence in elderly women: findings from the health, aging, and body composition study. Obstet Gynecol 104:301–307PubMedCrossRef
5.
Zurück zum Zitat Chou EC, Blaivas JG, Chou LW, Flisser AJ, Panagopoulos G (2008) Urodynamic characteristics of mixed urinary incontinence and idiopathic urge urinary incontinence. Neurourol Urodyn 27:376–378PubMedCrossRef Chou EC, Blaivas JG, Chou LW, Flisser AJ, Panagopoulos G (2008) Urodynamic characteristics of mixed urinary incontinence and idiopathic urge urinary incontinence. Neurourol Urodyn 27:376–378PubMedCrossRef
6.
Zurück zum Zitat Chu FM, Dmochowski R (2006) Pathophysiology of overactive bladder. Am J Med 119(3 Suppl 1):3–8PubMedCrossRef Chu FM, Dmochowski R (2006) Pathophysiology of overactive bladder. Am J Med 119(3 Suppl 1):3–8PubMedCrossRef
7.
Zurück zum Zitat Moehrer B, Hextall A, Jackson S (2003) Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev CD001405 Moehrer B, Hextall A, Jackson S (2003) Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev CD001405
8.
Zurück zum Zitat Liang W, Afshar K, Stothers L, Laher I (2002) The influence of ovariectomy and estrogen replacement on voiding patterns and detrusor muscarinic receptor affinity in the rat. Life Sci 71:351–362PubMedCrossRef Liang W, Afshar K, Stothers L, Laher I (2002) The influence of ovariectomy and estrogen replacement on voiding patterns and detrusor muscarinic receptor affinity in the rat. Life Sci 71:351–362PubMedCrossRef
9.
Zurück zum Zitat Skorupski P, Król J, Starega J, Adamiak A, Jankiewicz K, Rechberger T (2006) An alpha-1 chain of type I collagen Sp1-binding site polymorphism in women suffering from stress urinary incontinence. Am J Obstet Gynecol 194:346–350PubMedCrossRef Skorupski P, Król J, Starega J, Adamiak A, Jankiewicz K, Rechberger T (2006) An alpha-1 chain of type I collagen Sp1-binding site polymorphism in women suffering from stress urinary incontinence. Am J Obstet Gynecol 194:346–350PubMedCrossRef
10.
Zurück zum Zitat Abrams P (2003) Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology 28(5 Suppl 2):28–37CrossRef Abrams P (2003) Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology 28(5 Suppl 2):28–37CrossRef
11.
Zurück zum Zitat Blakeman PJ, Hilton P, Bulmer JN (1996) Mapping oestrogen and progesterone receptors throughout the female lower urinary tract. Neurourol Urodyn 15:324–325 Blakeman PJ, Hilton P, Bulmer JN (1996) Mapping oestrogen and progesterone receptors throughout the female lower urinary tract. Neurourol Urodyn 15:324–325
12.
Zurück zum Zitat Cardozo LD, Tapp A, Versi E et al (1987) The lower urinary tract in peri- and postmenopausal women in the urogenital oestrogen deficiency syndrome. In: Campbell S (ed) The management of the menopause and postmenopausal years. MTP Press, Lancaster, pp 10–17 Cardozo LD, Tapp A, Versi E et al (1987) The lower urinary tract in peri- and postmenopausal women in the urogenital oestrogen deficiency syndrome. In: Campbell S (ed) The management of the menopause and postmenopausal years. MTP Press, Lancaster, pp 10–17
13.
Zurück zum Zitat Shenfield OZ, Blackmore PF, Morgan CW et al (1998) Rapid effects of estriol and progesterone on tone and spontaneous rhythmic contractions of the rabbit bladder. Neurourol Urodyn 17:408–409 Shenfield OZ, Blackmore PF, Morgan CW et al (1998) Rapid effects of estriol and progesterone on tone and spontaneous rhythmic contractions of the rabbit bladder. Neurourol Urodyn 17:408–409
14.
Zurück zum Zitat Rud T (1980) The effects of estrogens and gestogens on the urethral pressure profile in urinary continent and stress incontinent women. Acta Obstet Gynecol Scand 59:265–270PubMedCrossRef Rud T (1980) The effects of estrogens and gestogens on the urethral pressure profile in urinary continent and stress incontinent women. Acta Obstet Gynecol Scand 59:265–270PubMedCrossRef
15.
Zurück zum Zitat Jackson S, Avery N, Shepherd A et al (1996) The effect of oestradiol on vaginal collagen in postmenopausal women with stress urinary incontinence. Neurourol Urodyn 15:327–328 Jackson S, Avery N, Shepherd A et al (1996) The effect of oestradiol on vaginal collagen in postmenopausal women with stress urinary incontinence. Neurourol Urodyn 15:327–328
16.
Zurück zum Zitat Ho MH, Bhatia NN, Bhasin S (2004) Anabolic effects of androgens on muscles of female pelvic floor and lower urinary tract. Curr Opin Obstet Gynecol 16:405–409PubMedCrossRef Ho MH, Bhatia NN, Bhasin S (2004) Anabolic effects of androgens on muscles of female pelvic floor and lower urinary tract. Curr Opin Obstet Gynecol 16:405–409PubMedCrossRef
Metadaten
Titel
Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways
verfasst von
J. N. Cornu
B. Merlet
O. Cussenot
G. Cancel-Tassin
C. Ciofu
G. Amarenco
F. Haab
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 2/2011
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-010-0585-8

Weitere Artikel der Ausgabe 2/2011

World Journal of Urology 2/2011 Zur Ausgabe

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.